Point prevalence survey reveals eligibility for de-labeling antibiotics among hospitalized patients, suggesting improved patient care.
As part of healthcare-associated infections prevalence survey, we examined the prevalence of antibiotic allergies among inpatients and the possibility to de-label reported penicillin and sulfa allergies. Results show that most of the patients with a penicillin or sulfa allergy label are eligible for either direct de-labeling or oral antibiotic challenge.
No takes yet. Share an insight, caveat, or question.
Sirkeoja et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: